Aurora Sheboygan Prices: Ado-Trastuzumab Emtansine 100 Milligram Intravenous Solution Costs $263.76
Ado-Trastuzumab Emtansine, also known as Kadcyla, is a targeted intravenous therapy primarily used for treating HER2-positive breast cancer. At Aurora Medical Center Sheboygan County, a 100-milligram dose is priced at $263.76. This fee generally covers the medication itself and basic administration, but may not include additional costs such as facility fees, infusion services, or required monitoring. Patients are advised to request an itemized estimate from the provider and confirm with their insurance regarding coverage and out-of-pocket responsibilities.
Cost Breakdown
- Medication Fee: $263.76 per 100mg dose
- Administration: Typically included, but confirm if nursing/infusion charges apply
- Facility Fee: May be billed separately by the hospital or outpatient center
- Monitoring & Labs: Blood tests and monitoring may incur additional costs
- Other Medications: Anti-nausea drugs or supportive treatments may be extra
Associated Costs
- Pre-treatment bloodwork and imaging
- Follow-up office visits
- Potential emergency care for side effects
- Supportive therapies (e.g., antiemetics, growth factors)
Insurance & Payment Advice
- Verify with your insurer if Ado-Trastuzumab Emtansine is covered and at what percentage
- Ask about prior authorization requirements
- Request an itemized bill to understand all charges
- Explore manufacturer assistance programs or hospital financial aid if needed
- Clarify co-pay and deductible obligations before starting treatment
Side-Effect Considerations
- Common side effects include fatigue, nausea, muscle or joint pain, and low platelet counts
- Serious risks may include liver toxicity and heart problems—regular monitoring is essential
- Discuss all symptoms with your care team promptly
Recovery and Support Tips
- Stay hydrated and maintain a balanced diet
- Arrange transportation for infusion days if you anticipate fatigue
- Follow all monitoring and lab work schedules as advised
- Seek support groups or counseling for emotional well-being
Frequently Asked Questions
-
What is Ado-Trastuzumab Emtansine used for?
Ado-Trastuzumab Emtansine is used to treat HER2-positive breast cancer by targeting and destroying cancer cells while minimizing damage to healthy cells. -
How is Ado-Trastuzumab Emtansine administered?
It is given as an intravenous infusion, typically in a hospital or clinic under professional supervision. -
What does the $263.76 fee cover?
This amount covers a 100mg dose of the medication, but additional costs for administration, facility use, and supportive care may apply. -
Will my insurance cover this treatment?
Coverage varies by insurer and plan; contact your insurance provider to confirm if Ado-Trastuzumab Emtansine is covered and what your out-of-pocket costs will be. -
Are there financial assistance programs available?
Yes, drug manufacturers and some hospitals offer financial aid or co-pay assistance for eligible patients. Ask your care team or financial counselor for more information. -
What are common side effects?
Common side effects include fatigue, nausea, muscle pain, and low platelet counts. More serious side effects are possible and should be discussed with your doctor. -
How often will I need this treatment?
The frequency depends on your treatment plan; your oncologist will provide a schedule tailored to your needs. -
Do I need to prepare for my infusion appointment?
You may be asked to have bloodwork done beforehand and should arrange for transportation if you expect to feel fatigued afterward. -
What should I do if I have side effects?
Contact your healthcare provider promptly to discuss any side effects or symptoms you experience during treatment. -
Can I get an itemized estimate before starting treatment?
Yes, you can and should request an itemized estimate from the hospital to understand all potential charges in advance. -
Are there alternatives to Ado-Trastuzumab Emtansine?
Other treatments for HER2-positive breast cancer are available; your oncologist can discuss the best options for your specific case.
Aurora Medical Center Sheboygan County, located at 3400 Union Ave, Sheboygan, WI, offers a range of medical services, including specialized cancer treatments. One such treatment is Ado-Trastuzumab Emtansine, an intravenous solution used primarily for patients with HER2-positive breast cancer. This medication combines the HER2-targeted action of trastuzumab with the cytotoxic activity of emtansine, providing a targeted approach to cancer treatment. According to Aurora Sheboygan’s pricing, the cost for a 100-milligram dose of Ado-Trastuzumab Emtansine is $263.76, reflecting the center’s commitment to providing advanced cancer therapies at competitive prices.
What is Ado-Trastuzumab Emtansine used for? – Ado-Trastuzumab Emtansine is used to treat HER2-positive breast cancer by targeting and destroying cancer cells while minimizing damage to healthy cells.
How is Ado-Trastuzumab Emtansine administered? – It is administered intravenously, meaning it is given through a vein, typically in a hospital or clinical setting under the supervision of healthcare professionals.
What are the potential side effects of Ado-Trastuzumab Emtansine? – Common side effects include fatigue, nausea, musculoskeletal pain, and low blood platelet levels, but patients should consult their doctors for a comprehensive list of potential side effects.
How does the cost of Ado-Trastuzumab Emtansine at Aurora compare to other facilities? – The cost of $263.76 for a 100 mg dose at Aurora Medical Center Sheboygan County is competitive, but prices may vary based on location and insurance coverage.
Is Ado-Trastuzumab Emtansine covered by insurance? – Coverage for Ado-Trastuzumab Emtansine depends on individual insurance plans, and patients should contact their insurance providers to confirm coverage details.
How often is Ado-Trastuzumab Emtansine administered? – The frequency of administration is determined by the treating oncologist and typically follows a specific treatment protocol tailored to the patient’s needs.
Can Ado-Trastuzumab Emtansine be used in combination with other treatments? – Yes, it is often used in combination with other cancer treatments, but the specific regimen should be determined by a healthcare professional based on the patient’s condition.
What should patients do if they experience side effects from Ado-Trastuzumab Emtansine? – Patients should immediately report any side effects to their healthcare provider to manage symptoms and adjust treatment if necessary.
